Loading...
XLON
TATE
Market cap3.31bUSD
Jul 10, Last price  
557.00GBP
1D
0.00%
1Q
55.02%
Jan 2017
-32.52%
Name

Tate & Lyle PLC

Chart & Performance

D1W1MN
XLON:TATE chart
P/E
25.41
P/S
1.23
EPS
0.22
Div Yield, %
3.59%
Shrs. gr., 5y
2.14%
Rev. gr., 5y
10.62%
Revenues
2.01b
+15.55%
3,225,000,0002,867,000,0003,553,000,0002,533,000,0002,720,000,0003,088,000,0003,256,000,0002,754,000,0002,341,000,0002,355,000,0002,753,000,0002,710,000,0002,755,000,0002,882,000,0001,211,000,0001,375,000,0001,751,000,0001,647,000,0001,736,000,0002,006,000,000
Net income
97m
-32.17%
214,000,000194,000,00065,000,00015,000,000163,000,000305,000,000272,000,000273,000,00030,000,000163,000,000256,000,000265,000,000181,000,000245,000,000253,000,000236,000,000190,000,000188,000,000143,000,00097,000,000
CFO
238m
+45.12%
227,000,000162,000,000501,000,000522,000,000122,000,000231,000,000251,000,000286,000,000179,000,000188,000,000298,000,000286,000,000330,000,000385,000,000369,000,000103,000,00066,000,000208,000,000164,000,000238,000,000
Dividend
Nov 20, 20256.6 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1903 and headquartered in London, United Kingdom, Tate & Lyle PLC is a global provider of specialized ingredients and solutions. The company caters to the food, beverage, and other industrial sectors across the United States, the United Kingdom, other European nations, and numerous international markets. Its operations are organized into three principal segments: Food & Beverage Solutions, Sucralose, and Primary Products. Tate & Lyle's diverse product portfolio encompasses texturants, health and wellness components, and stabilizers. They also supply nutritive sweeteners, such as high-fructose corn syrup and dextrose. Beyond food-related offerings, the company manufactures industrial starches for applications like paper, packaging, and adhesives, alongside acidulants like citric acid. Furthermore, they deal in various commodities, including corn gluten feed and meal for animal nutrition, corn oil, and ethanol. The company's activities extend to treasury, insurance, and vital research and development services.
IPO date
Dec 09, 1938
Employees
3,604
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT